BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nakamura K, Kageyama S, Kupiec-Weglinski JW. The Evolving Role of Neutrophils in Liver Transplant Ischemia-Reperfusion Injury. Curr Transplant Rep 2019;6:78-89. [PMID: 31602356 DOI: 10.1007/s40472-019-0230-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang Z, Zhang P, Wang Q, Sheng X, Zhang J, Lu X, Fan X. Protective effects of Ginkgo Biloba Dropping Pills against liver ischemia/reperfusion injury in mice. Chin Med 2020;15:122. [PMID: 33292377 DOI: 10.1186/s13020-020-00404-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Zhang Y, Pan Q, Liu Y. CXCL16 silencing alleviates hepatic ischemia reperfusion injury during liver transplantation by inhibiting p38 phosphorylation. Pathology - Research and Practice 2020;216:152913. [DOI: 10.1016/j.prp.2020.152913] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
3 Ni X, Wu X, Zhu X, Li J, Yin X, Lu L. Carabin Deficiency Aggravates Hepatic Ischemia-Reperfusion Injury Through Promoting Neutrophil Trafficking via Ras and Calcineurin Signaling. Front Immunol 2022;13:773291. [DOI: 10.3389/fimmu.2022.773291] [Reference Citation Analysis]
4 Hirao H, Nakamura K, Kupiec-Weglinski JW. Liver ischaemia-reperfusion injury: a new understanding of the role of innate immunity. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34837066 DOI: 10.1038/s41575-021-00549-8] [Reference Citation Analysis]
5 Ung N, Goldbeck C, Man C, Hoeflich J, Sun R, Barbetta A, Matasci N, Katz J, Lee JSH, Chopra S, Asgharzadeh S, Warren M, Sher L, Kohli R, Akbari O, Genyk Y, Emamaullee J. Adaptation of Imaging Mass Cytometry to Explore the Single Cell Alloimmune Landscape of Liver Transplant Rejection. Front Immunol 2022;13:831103. [DOI: 10.3389/fimmu.2022.831103] [Reference Citation Analysis]
6 Masior Ł, Grąt M. Methods of Attenuating Ischemia-Reperfusion Injury in Liver Transplantation for Hepatocellular Carcinoma. Int J Mol Sci 2021;22:8229. [PMID: 34360995 DOI: 10.3390/ijms22158229] [Reference Citation Analysis]
7 Hashemi P, Nouri-Vaskeh M, Alizadeh L, Baghbanzadeh A, Badalzadeh R, Askari E, Baradaran B. NETosis in ischemic/reperfusion injuries: An organ-based review. Life Sci 2021;290:120158. [PMID: 34822798 DOI: 10.1016/j.lfs.2021.120158] [Reference Citation Analysis]
8 Yang JY, Li M, Zhang CL, Liu D. Pharmacological properties of baicalin on liver diseases: a narrative review. Pharmacol Rep 2021;73:1230-9. [PMID: 33595821 DOI: 10.1007/s43440-021-00227-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Lu T, Zhang J, Cai J, Xiao J, Sui X, Yuan X, Li R, Li Y, Yao J, Lv G, Chen X, Chen H, Zeng K, Liu Y, Chen W, Chen G, Yang Y, Zheng J, Zhang Y. Extracellular vesicles derived from mesenchymal stromal cells as nanotherapeutics for liver ischaemia–reperfusion injury by transferring mitochondria to modulate the formation of neutrophil extracellular traps'. Biomaterials 2022. [DOI: 10.1016/j.biomaterials.2022.121486] [Reference Citation Analysis]
10 Nemeth N, Peto K, Magyar Z, Klarik Z, Varga G, Oltean M, Mantas A, Czigany Z, Tolba RH. Hemorheological and Microcirculatory Factors in Liver Ischemia-Reperfusion Injury-An Update on Pathophysiology, Molecular Mechanisms and Protective Strategies. Int J Mol Sci 2021;22:1864. [PMID: 33668478 DOI: 10.3390/ijms22041864] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Zhang H, Li Z, Li W. M2 Macrophages Serve as Critical Executor of Innate Immunity in Chronic Allograft Rejection. Front Immunol 2021;12:648539. [PMID: 33815407 DOI: 10.3389/fimmu.2021.648539] [Reference Citation Analysis]
12 Liu Y, Qin X, Lei Z, Chai H, Huang Z, Wu Z. Tetramethylpyrazine inhibits neutrophil extracellular traps formation and alleviates hepatic ischemia/reperfusion injury in rat liver transplantation. Exp Cell Res 2021;406:112719. [PMID: 34273405 DOI: 10.1016/j.yexcr.2021.112719] [Reference Citation Analysis]
13 Nakamura K, Kageyama S, Kupiec-Weglinski JW. Innate immunity in ischemia-reperfusion injury and graft rejection. Curr Opin Organ Transplant 2019;24:687-93. [PMID: 31592839 DOI: 10.1097/MOT.0000000000000709] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
14 Nakamura K, Kageyama S, Kaldas FM, Hirao H, Ito T, Kadono K, Dery KJ, Kojima H, Gjertson DW, Sosa RA, Kujawski M, Busuttil RW, Reed EF, Kupiec-Weglinski JW. Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. J Clin Invest 2020;130:2689-704. [PMID: 32027621 DOI: 10.1172/JCI133142] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]